Hydropothecary Raises $149.5 Million Selling Units at $4.00

Hydropothecary Closes Offering of Units for $149.5 Million

GATINEAU, QC–(Marketwired – January 30, 2018) –

The Hydropothecary Corporation (“THCX” or the “Company”) (TSX VENTURE: THCX) announced today that it has closed its previously disclosed bought deal public offering (the “Offering”) of units of the Company (the “Units”) for aggregate gross proceeds of $149,500,000, including the exercise, in full, of the over-allotment option. The Offering was underwritten by a syndicate of underwriters led by Canaccord Genuity Corp. and Eight Capital and including Cormark Securities Inc., GMP Securities L.P. and Beacon Securities Limited (the “Underwriters”).

Under ​​the ​​Offering, ​​the ​​Company ​​issued 37,375,000 units ​​at ​​a ​​price ​​of ​​$4.00 ​​per u​nit, ​​including 4,875,000 units issued ​​pursuant ​​to ​​the ​​exercise ​​of ​​the ​​over-allotment ​​option. ​​ Each Unit is composed of one common share of the Company and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant is exercisable into one common share of the Company at an exercise price per share of $5.60 for a period of two years from the date of issue.

The Company intends to use the net proceeds of the Offering to acquire additional production equipment, further expand and increase the Company’s production, processing and distribution capacity, develop distribution channels in the adult recreational use market across Canada, explore international business development opportunities, and make strategic investments through acquisitions, partnerships or development of additional in-house capacity to broaden and diversify the Company’s product offering. Additional ​​information ​​on ​​the ​​expected ​​use ​​of the ​​net ​​proceeds ​​from ​​the ​​Offering ​​is ​​disclosed ​​in ​​the ​​short ​​form ​​prospectus for the Offering.

The Offering is subject to final acceptance of the TSX Venture Exchange (“TSXV”). The TSXV has conditionally accepted the Offering and the listing of the common shares and Warrants. Subject ​​to ​​the ​​Company fulfilling ​​the ​​listing ​​requirements ​​of ​​the ​​TSXV, ​​it ​​is ​​expected ​​that ​​the Warrants ​​will commence ​​trading ​​on ​​the ​​TSXV ​​at ​​market ​​open ​​on ​​Friday, February 2, ​​2018.

About The Hydropothecary Corporation

The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary creates award-winning innovative, easy to use and easy to understand products. Hydropothecary is rapidly increasing its production capacity in the lead-up to recreational adult-use cannabis. Expansion plans will result in a total of 1.3 million sq. ft. of production space, producing 108,000 kg of dried cannabis per year, making Hydropothecary one of the largest producers in the country. With industry-leading cash cost per gram of $0.89, Hydropothecary is the lowest cost producer in the country. The first licensed producer in Quebec, Hydropothecary is headquartered in the province.

Original press release

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.


Get Our Sunday Newsletter